Methylthioadenosine phosphorylase in human breast cancer

Breast Cancer Res Treat. 1987;9(1):53-9. doi: 10.1007/BF01806694.

Abstract

Methylthioadenosine (MTA) phosphorylase activity was measured in 47 biopsies from primary breast cancers (n = 34) and metastatic tumors (n = 13). Most specimens were also evaluated by DNA flow cytometry and determination of estrogen and progesterone receptor contents. Median MTA phosphorylase activity was 317 pmol/mg protein/min (range 50-1312 pmol/mg protein/min), but great variations were observed. Samples from four individuals had very low MTA phosphorylase activity (less than or equal to 70 pmol/mg protein/min). No correlation with aneuploidy, receptor status, or the presence of metastases in the lymph nodes could be demonstrated. However, MTA phosphorylase activity showed a significant (p = 0.009) negative correlation with the fraction of cells in the S-phase of the cell cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / pathology
  • DNA, Neoplasm / analysis
  • Female
  • Flow Cytometry
  • Humans
  • Interphase
  • Middle Aged
  • Pentosyltransferases / analysis*
  • Purine-Nucleoside Phosphorylase / analysis*

Substances

  • DNA, Neoplasm
  • Pentosyltransferases
  • Purine-Nucleoside Phosphorylase
  • 5'-methylthioadenosine phosphorylase